相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemia
Giovanni Rossi et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2022)
Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry
Weijie Li et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2021)
Leukemia-associated immunophenotypes subdivided in categories of specificity improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia
Giovanni Rossi et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2020)
The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1
Lei Shang et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1
Yi Zhou et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Gerrit J. Schuurhuis et al.
BLOOD (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia
Betul Oran et al.
HAEMATOLOGICA (2017)
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia
Betul Oran et al.
HAEMATOLOGICA (2017)
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
Ying-Jun Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Measurable residual disease testing in acute myeloid leukaemia
C. S. Hourigan et al.
LEUKEMIA (2017)
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation
Bartlomiej M. Getta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
Christophe Willekens et al.
HAEMATOLOGICA (2016)
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
Christophe Willekens et al.
HAEMATOLOGICA (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
R. B. Walter et al.
LEUKEMIA (2015)
Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)
Lixia Zhang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
Sylvie D. Freeman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
Francesco Buccisano et al.
BLOOD (2012)
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
Hiroto Inaba et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Acute Myeloid Leukemia Clinical Practice Guidelines in Oncology
Margaret R. O'Donnell et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia
Takuya Miyazaki et al.
LEUKEMIA RESEARCH (2012)
Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
Hakon Reikvam et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia
Francesco Buccisano et al.
BLOOD (2010)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E. Rubnitz et al.
LANCET ONCOLOGY (2010)
Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia
Jiazhuo Liu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China
Y. Cheng et al.
LEUKEMIA (2009)
Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry
Adhra Al-Mawali et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
A >= 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse
Steven Lane et al.
LEUKEMIA & LYMPHOMA (2008)
Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype
Yingchang Mi et al.
LEUKEMIA & LYMPHOMA (2008)
Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia
RN Sanderson et al.
LEUKEMIA (2006)
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring
C Langebrake et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization
M Klaus et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
Determination of minimal residual disease in leukaemia patients
D Campana
BRITISH JOURNAL OF HAEMATOLOGY (2003)
High frequency of immunophenotype changes in acute myeloid leukemia at relapse:: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
MR Baer et al.
BLOOD (2001)
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease
ER van Wering et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
